 Fernando Kim
Concepts (334)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laparoscopy | 30 | 2018 | 466 | 5.370 |
Why?
| | Cryosurgery | 12 | 2025 | 59 | 4.190 |
Why?
| | Prostatic Neoplasms | 17 | 2024 | 1043 | 2.450 |
Why?
| | Kidney Neoplasms | 14 | 2025 | 403 | 2.440 |
Why?
| | Nephrectomy | 13 | 2022 | 169 | 1.930 |
Why?
| | Carcinoma, Renal Cell | 8 | 2022 | 217 | 1.840 |
Why?
| | Minimally Invasive Surgical Procedures | 6 | 2015 | 179 | 1.440 |
Why?
| | Prostatectomy | 10 | 2024 | 104 | 1.330 |
Why?
| | Urologic Surgical Procedures | 8 | 2012 | 120 | 1.260 |
Why?
| | Robotics | 8 | 2022 | 94 | 1.030 |
Why?
| | Laparoscopes | 4 | 2014 | 11 | 0.990 |
Why?
| | Urology | 4 | 2015 | 63 | 0.980 |
Why?
| | Ergonomics | 3 | 2015 | 26 | 0.910 |
Why?
| | Sodium Chloride | 2 | 2015 | 142 | 0.890 |
Why?
| | Ureter | 2 | 2014 | 36 | 0.830 |
Why?
| | Ultrasonic Surgical Procedures | 2 | 2014 | 4 | 0.830 |
Why?
| | Ureteroscopy | 6 | 2016 | 18 | 0.810 |
Why?
| | Kidney Calculi | 5 | 2024 | 38 | 0.810 |
Why?
| | Prostate | 5 | 2024 | 175 | 0.800 |
Why?
| | Dissection | 2 | 2014 | 52 | 0.790 |
Why?
| | Robotic Surgical Procedures | 4 | 2022 | 130 | 0.780 |
Why?
| | Pelvis | 2 | 2015 | 102 | 0.770 |
Why?
| | Endoscopy | 3 | 2013 | 318 | 0.730 |
Why?
| | Treatment Outcome | 28 | 2025 | 10811 | 0.730 |
Why?
| | Lithotripsy, Laser | 4 | 2016 | 8 | 0.710 |
Why?
| | Urinary Calculi | 2 | 2014 | 12 | 0.700 |
Why?
| | Cryotherapy | 2 | 2025 | 17 | 0.690 |
Why?
| | Lithotripsy | 3 | 2013 | 48 | 0.670 |
Why?
| | Salvage Therapy | 2 | 2018 | 142 | 0.650 |
Why?
| | Prostatic Hyperplasia | 2 | 2015 | 44 | 0.580 |
Why?
| | Equipment Failure Analysis | 2 | 2015 | 132 | 0.570 |
Why?
| | Ultrasonics | 2 | 2014 | 49 | 0.550 |
Why?
| | Urethra | 3 | 2013 | 55 | 0.510 |
Why?
| | Ureteral Calculi | 3 | 2014 | 14 | 0.500 |
Why?
| | Humans | 80 | 2025 | 137585 | 0.490 |
Why?
| | Lasers, Solid-State | 2 | 2014 | 22 | 0.470 |
Why?
| | Biopsy | 4 | 2024 | 1129 | 0.470 |
Why?
| | Equipment Design | 6 | 2014 | 522 | 0.450 |
Why?
| | Musculoskeletal Pain | 1 | 2015 | 37 | 0.450 |
Why?
| | Urinary Tract | 3 | 2023 | 51 | 0.450 |
Why?
| | Kidney | 6 | 2019 | 1468 | 0.440 |
Why?
| | Consumer Behavior | 1 | 2015 | 71 | 0.440 |
Why?
| | Male | 44 | 2025 | 67762 | 0.440 |
Why?
| | Aged | 28 | 2025 | 23961 | 0.430 |
Why?
| | Carcinoid Tumor | 2 | 2018 | 26 | 0.420 |
Why?
| | Laser Therapy | 1 | 2015 | 130 | 0.420 |
Why?
| | Operative Time | 4 | 2015 | 145 | 0.420 |
Why?
| | Video-Assisted Surgery | 1 | 2013 | 4 | 0.420 |
Why?
| | Intraoperative Complications | 2 | 2013 | 138 | 0.420 |
Why?
| | Penile Neoplasms | 1 | 2013 | 7 | 0.420 |
Why?
| | Prostate-Specific Antigen | 5 | 2023 | 162 | 0.410 |
Why?
| | Ureterostomy | 1 | 2013 | 3 | 0.410 |
Why?
| | Cystostomy | 1 | 2013 | 9 | 0.400 |
Why?
| | Retrospective Studies | 23 | 2025 | 15657 | 0.380 |
Why?
| | Lymph Node Excision | 1 | 2013 | 171 | 0.380 |
Why?
| | Patient Preference | 1 | 2014 | 191 | 0.370 |
Why?
| | Hysterectomy | 1 | 2013 | 129 | 0.370 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2018 | 1079 | 0.370 |
Why?
| | Middle Aged | 29 | 2025 | 33479 | 0.370 |
Why?
| | Hot Temperature | 1 | 2014 | 391 | 0.360 |
Why?
| | Surgical Equipment | 1 | 2011 | 11 | 0.360 |
Why?
| | Diabetic Nephropathies | 1 | 2015 | 294 | 0.360 |
Why?
| | Pelvic Bones | 1 | 2013 | 129 | 0.360 |
Why?
| | Drug Delivery Systems | 1 | 2013 | 365 | 0.330 |
Why?
| | Suture Techniques | 2 | 2023 | 122 | 0.320 |
Why?
| | Wounds, Nonpenetrating | 2 | 2013 | 278 | 0.310 |
Why?
| | Fournier Gangrene | 1 | 2009 | 3 | 0.310 |
Why?
| | Hydrotherapy | 1 | 2009 | 8 | 0.310 |
Why?
| | Hydrocarbons | 1 | 2009 | 31 | 0.300 |
Why?
| | Penis | 1 | 2009 | 36 | 0.300 |
Why?
| | Scrotum | 1 | 2009 | 27 | 0.300 |
Why?
| | Debridement | 1 | 2009 | 81 | 0.300 |
Why?
| | Clinical Medicine | 1 | 2008 | 25 | 0.300 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2015 | 617 | 0.290 |
Why?
| | Mediastinal Diseases | 1 | 2007 | 10 | 0.280 |
Why?
| | Adult | 25 | 2025 | 37929 | 0.270 |
Why?
| | Abdominal Injuries | 1 | 2008 | 123 | 0.260 |
Why?
| | Tomography, X-Ray Computed | 8 | 2016 | 2691 | 0.260 |
Why?
| | Reproducibility of Results | 4 | 2018 | 3284 | 0.260 |
Why?
| | Neoplasm Grading | 4 | 2016 | 307 | 0.250 |
Why?
| | Urinary Bladder | 1 | 2008 | 183 | 0.250 |
Why?
| | Urinary Incontinence | 4 | 2014 | 66 | 0.240 |
Why?
| | Vas Deferens | 1 | 2005 | 12 | 0.240 |
Why?
| | Sarcoidosis | 1 | 2007 | 159 | 0.240 |
Why?
| | Blood Loss, Surgical | 3 | 2015 | 101 | 0.240 |
Why?
| | Ureterolithiasis | 2 | 2016 | 2 | 0.230 |
Why?
| | Hernia, Inguinal | 1 | 2005 | 36 | 0.230 |
Why?
| | Quality of Life | 2 | 2023 | 2892 | 0.230 |
Why?
| | Body Mass Index | 1 | 2013 | 2389 | 0.230 |
Why?
| | Postoperative Complications | 8 | 2025 | 2654 | 0.220 |
Why?
| | Amino Acid Transport Systems, Basic | 1 | 2023 | 5 | 0.210 |
Why?
| | Nephrostomy, Percutaneous | 3 | 2014 | 9 | 0.210 |
Why?
| | Cystinuria | 1 | 2023 | 4 | 0.210 |
Why?
| | Testicular Diseases | 1 | 2003 | 7 | 0.210 |
Why?
| | Nomograms | 1 | 2024 | 54 | 0.210 |
Why?
| | Incisional Hernia | 1 | 2023 | 3 | 0.210 |
Why?
| | Cystine | 1 | 2023 | 18 | 0.210 |
Why?
| | Abdominal Wound Closure Techniques | 1 | 2023 | 7 | 0.210 |
Why?
| | Frail Elderly | 1 | 2024 | 131 | 0.200 |
Why?
| | Aged, 80 and over | 8 | 2024 | 7635 | 0.200 |
Why?
| | Solitary Kidney | 1 | 2022 | 5 | 0.200 |
Why?
| | Digestive System Surgical Procedures | 1 | 2023 | 106 | 0.190 |
Why?
| | Apoptosis | 1 | 2011 | 2553 | 0.190 |
Why?
| | Feasibility Studies | 4 | 2013 | 956 | 0.180 |
Why?
| | Sheep | 2 | 2014 | 856 | 0.180 |
Why?
| | Surgeons | 2 | 2023 | 297 | 0.180 |
Why?
| | Urinary Bladder Neoplasms | 2 | 2018 | 252 | 0.180 |
Why?
| | Cattle | 2 | 2014 | 984 | 0.170 |
Why?
| | Urologic Diseases | 2 | 2011 | 41 | 0.170 |
Why?
| | Risk Factors | 8 | 2015 | 10388 | 0.170 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2015 | 2531 | 0.170 |
Why?
| | Retroperitoneal Neoplasms | 2 | 2013 | 25 | 0.170 |
Why?
| | Marital Status | 2 | 2014 | 44 | 0.170 |
Why?
| | Tissue Donors | 1 | 2003 | 425 | 0.160 |
Why?
| | Obesity | 1 | 2013 | 2992 | 0.160 |
Why?
| | Follow-Up Studies | 5 | 2025 | 5131 | 0.160 |
Why?
| | Female | 22 | 2025 | 73304 | 0.150 |
Why?
| | Image-Guided Biopsy | 2 | 2024 | 39 | 0.150 |
Why?
| | Catheter Ablation | 1 | 2022 | 350 | 0.150 |
Why?
| | Guidelines as Topic | 1 | 2019 | 275 | 0.140 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2015 | 1477 | 0.130 |
Why?
| | Wounds and Injuries | 1 | 2024 | 758 | 0.130 |
Why?
| | Kidney Transplantation | 1 | 2003 | 708 | 0.130 |
Why?
| | Hematoma | 1 | 2016 | 53 | 0.130 |
Why?
| | Spectrum Analysis | 1 | 2016 | 91 | 0.120 |
Why?
| | Injury Severity Score | 2 | 2019 | 522 | 0.120 |
Why?
| | Transurethral Resection of Prostate | 1 | 2015 | 3 | 0.120 |
Why?
| | Adrenalectomy | 1 | 2015 | 68 | 0.120 |
Why?
| | Volatilization | 1 | 2015 | 56 | 0.120 |
Why?
| | Postoperative Hemorrhage | 1 | 2016 | 86 | 0.120 |
Why?
| | Erectile Dysfunction | 2 | 2013 | 39 | 0.120 |
Why?
| | Survival Analysis | 2 | 2017 | 1325 | 0.120 |
Why?
| | Adrenal Cortex Neoplasms | 1 | 2015 | 63 | 0.110 |
Why?
| | Organ Sparing Treatments | 1 | 2014 | 34 | 0.110 |
Why?
| | Adrenocortical Carcinoma | 1 | 2015 | 65 | 0.110 |
Why?
| | Renal Veins | 1 | 2014 | 19 | 0.110 |
Why?
| | Urinary Bladder Neck Obstruction | 1 | 2014 | 21 | 0.110 |
Why?
| | Watchful Waiting | 1 | 2015 | 81 | 0.110 |
Why?
| | Intraoperative Period | 1 | 2014 | 59 | 0.110 |
Why?
| | Incidental Findings | 1 | 2015 | 87 | 0.110 |
Why?
| | Male Urogenital Diseases | 1 | 2014 | 3 | 0.110 |
Why?
| | Mesentery | 1 | 2014 | 48 | 0.110 |
Why?
| | Female Urogenital Diseases | 1 | 2014 | 7 | 0.110 |
Why?
| | Holmium | 1 | 2014 | 1 | 0.110 |
Why?
| | Wyoming | 1 | 2014 | 36 | 0.110 |
Why?
| | Yttrium | 1 | 2014 | 5 | 0.110 |
Why?
| | Hemostatic Techniques | 1 | 2014 | 46 | 0.110 |
Why?
| | Animals | 8 | 2015 | 36940 | 0.110 |
Why?
| | Rectal Fistula | 1 | 2014 | 28 | 0.110 |
Why?
| | Length of Stay | 2 | 2017 | 1215 | 0.110 |
Why?
| | Equipment Failure | 1 | 2014 | 108 | 0.110 |
Why?
| | Aluminum | 1 | 2014 | 42 | 0.110 |
Why?
| | Inguinal Canal | 1 | 2013 | 10 | 0.100 |
Why?
| | Abdominal Wall | 1 | 2013 | 24 | 0.100 |
Why?
| | Cystadenoma, Mucinous | 1 | 2013 | 13 | 0.100 |
Why?
| | Autopsy | 1 | 2013 | 95 | 0.100 |
Why?
| | Urinary Catheterization | 1 | 2013 | 33 | 0.100 |
Why?
| | Nephrolithiasis | 1 | 2013 | 11 | 0.100 |
Why?
| | Regression Analysis | 2 | 2013 | 1024 | 0.100 |
Why?
| | Biopsy, Large-Core Needle | 1 | 2012 | 14 | 0.100 |
Why?
| | Remission Induction | 1 | 2013 | 288 | 0.100 |
Why?
| | Materials Testing | 1 | 2014 | 356 | 0.100 |
Why?
| | Wounds, Penetrating | 1 | 2013 | 65 | 0.100 |
Why?
| | Adenoma | 1 | 2014 | 230 | 0.100 |
Why?
| | Time Factors | 4 | 2025 | 6828 | 0.100 |
Why?
| | Computer Systems | 1 | 2012 | 45 | 0.100 |
Why?
| | Brazil | 1 | 2012 | 167 | 0.100 |
Why?
| | Natural Orifice Endoscopic Surgery | 1 | 2012 | 34 | 0.090 |
Why?
| | Models, Animal | 2 | 2011 | 384 | 0.090 |
Why?
| | Particle Size | 1 | 2013 | 394 | 0.090 |
Why?
| | Constriction, Pathologic | 1 | 2013 | 245 | 0.090 |
Why?
| | Insurance, Health | 1 | 2014 | 283 | 0.090 |
Why?
| | Acute Kidney Injury | 1 | 2019 | 815 | 0.090 |
Why?
| | Microsurgery | 1 | 2012 | 75 | 0.090 |
Why?
| | Reference Values | 1 | 2013 | 816 | 0.090 |
Why?
| | Logistic Models | 2 | 2014 | 2074 | 0.090 |
Why?
| | Temperature | 1 | 2014 | 679 | 0.090 |
Why?
| | Urologic Neoplasms | 1 | 2011 | 31 | 0.090 |
Why?
| | Sus scrofa | 1 | 2011 | 52 | 0.090 |
Why?
| | Neoplasm Metastasis | 1 | 2013 | 658 | 0.090 |
Why?
| | Surgicenters | 1 | 2010 | 6 | 0.090 |
Why?
| | Models, Theoretical | 1 | 2014 | 578 | 0.090 |
Why?
| | Rectum | 3 | 2024 | 185 | 0.090 |
Why?
| | Esthetics | 1 | 2011 | 51 | 0.090 |
Why?
| | Trauma Centers | 1 | 2013 | 421 | 0.090 |
Why?
| | Necrosis | 1 | 2011 | 246 | 0.090 |
Why?
| | Terminology as Topic | 2 | 2009 | 216 | 0.080 |
Why?
| | Prone Position | 1 | 2010 | 30 | 0.080 |
Why?
| | Cicatrix | 1 | 2011 | 64 | 0.080 |
Why?
| | Learning Curve | 1 | 2011 | 72 | 0.080 |
Why?
| | Surgery, Computer-Assisted | 1 | 2011 | 101 | 0.080 |
Why?
| | Supine Position | 1 | 2010 | 39 | 0.080 |
Why?
| | Blood Vessels | 1 | 2011 | 187 | 0.080 |
Why?
| | Magnetic Resonance Imaging | 3 | 2024 | 3566 | 0.080 |
Why?
| | Psychomotor Performance | 1 | 2012 | 309 | 0.080 |
Why?
| | Risk Assessment | 3 | 2015 | 3457 | 0.080 |
Why?
| | Computer Simulation | 1 | 2013 | 978 | 0.080 |
Why?
| | Severity of Illness Index | 2 | 2015 | 2828 | 0.080 |
Why?
| | Valproic Acid | 1 | 2009 | 48 | 0.080 |
Why?
| | Forecasting | 1 | 2011 | 389 | 0.080 |
Why?
| | Soft Tissue Injuries | 1 | 2009 | 33 | 0.070 |
Why?
| | Lacerations | 1 | 2009 | 35 | 0.070 |
Why?
| | Fractures, Bone | 1 | 2013 | 380 | 0.070 |
Why?
| | Skin Transplantation | 1 | 2009 | 85 | 0.070 |
Why?
| | Rectal Diseases | 1 | 2008 | 23 | 0.070 |
Why?
| | Urinary Bladder Diseases | 1 | 2008 | 19 | 0.070 |
Why?
| | Pneumatosis Cystoides Intestinalis | 1 | 2008 | 21 | 0.070 |
Why?
| | Kidney Medulla | 1 | 2008 | 35 | 0.070 |
Why?
| | Rupture | 1 | 2008 | 92 | 0.070 |
Why?
| | Intestinal Perforation | 1 | 2008 | 46 | 0.070 |
Why?
| | Kidney Diseases | 1 | 2012 | 408 | 0.070 |
Why?
| | Disease Models, Animal | 3 | 2014 | 4295 | 0.070 |
Why?
| | Kidney Tubules, Collecting | 1 | 2008 | 31 | 0.070 |
Why?
| | Practice Patterns, Physicians' | 2 | 2006 | 1313 | 0.070 |
Why?
| | Endometriosis | 1 | 2008 | 51 | 0.070 |
Why?
| | Radionuclide Imaging | 1 | 2007 | 118 | 0.070 |
Why?
| | Adenocarcinoma | 1 | 2014 | 940 | 0.070 |
Why?
| | Cell Separation | 1 | 2008 | 318 | 0.070 |
Why?
| | Academic Medical Centers | 1 | 2010 | 512 | 0.070 |
Why?
| | Antineoplastic Agents | 2 | 2009 | 2129 | 0.070 |
Why?
| | Europe | 3 | 2014 | 414 | 0.070 |
Why?
| | Pyrroles | 1 | 2008 | 213 | 0.070 |
Why?
| | Cohort Studies | 4 | 2014 | 5742 | 0.070 |
Why?
| | Tumor Cells, Cultured | 1 | 2008 | 955 | 0.060 |
Why?
| | Age Factors | 1 | 2014 | 3295 | 0.060 |
Why?
| | Neurilemmoma | 1 | 2006 | 24 | 0.060 |
Why?
| | Wound Healing | 1 | 2009 | 331 | 0.060 |
Why?
| | Cell Culture Techniques | 1 | 2008 | 363 | 0.060 |
Why?
| | Vulnerable Populations | 1 | 2006 | 163 | 0.060 |
Why?
| | Societies, Medical | 1 | 2009 | 820 | 0.060 |
Why?
| | Predictive Value of Tests | 2 | 2012 | 2031 | 0.060 |
Why?
| | Indoles | 1 | 2008 | 412 | 0.060 |
Why?
| | Treatment Failure | 1 | 2006 | 356 | 0.060 |
Why?
| | Ultrasonography | 2 | 2012 | 759 | 0.060 |
Why?
| | Remote Consultation | 1 | 2004 | 54 | 0.050 |
Why?
| | Urinary Incontinence, Stress | 1 | 2003 | 15 | 0.050 |
Why?
| | Epithelioid Cells | 1 | 2003 | 9 | 0.050 |
Why?
| | Disease-Free Survival | 1 | 2025 | 686 | 0.050 |
Why?
| | Angiomyolipoma | 1 | 2003 | 24 | 0.050 |
Why?
| | Iatrogenic Disease | 1 | 2023 | 67 | 0.050 |
Why?
| | Hematuria | 2 | 2018 | 12 | 0.050 |
Why?
| | Laparotomy | 1 | 2023 | 109 | 0.050 |
Why?
| | Postoperative Care | 1 | 2004 | 261 | 0.050 |
Why?
| | Organ Size | 2 | 2014 | 477 | 0.050 |
Why?
| | Microwaves | 1 | 2022 | 37 | 0.050 |
Why?
| | Geriatric Assessment | 1 | 2024 | 224 | 0.050 |
Why?
| | Gene Frequency | 1 | 2023 | 521 | 0.050 |
Why?
| | Genetics, Population | 1 | 2023 | 214 | 0.050 |
Why?
| | Biomarkers, Tumor | 1 | 2008 | 1276 | 0.040 |
Why?
| | Cell Proliferation | 1 | 2009 | 2475 | 0.040 |
Why?
| | Frailty | 1 | 2024 | 170 | 0.040 |
Why?
| | Health Care Surveys | 2 | 2018 | 565 | 0.040 |
Why?
| | Reoperation | 1 | 2023 | 573 | 0.040 |
Why?
| | Prognosis | 3 | 2016 | 4030 | 0.040 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 350 | 0.040 |
Why?
| | Patient Satisfaction | 1 | 2004 | 660 | 0.040 |
Why?
| | Cystoscopy | 1 | 2018 | 21 | 0.040 |
Why?
| | Incidence | 3 | 2012 | 2804 | 0.040 |
Why?
| | Pain | 1 | 2003 | 756 | 0.040 |
Why?
| | Patient Positioning | 1 | 2018 | 67 | 0.030 |
Why?
| | General Surgery | 1 | 2019 | 173 | 0.030 |
Why?
| | Triage | 1 | 2019 | 222 | 0.030 |
Why?
| | Multivariate Analysis | 2 | 2014 | 1509 | 0.030 |
Why?
| | Radiography | 2 | 2010 | 822 | 0.030 |
Why?
| | Support Vector Machine | 1 | 2016 | 38 | 0.030 |
Why?
| | Prospective Studies | 4 | 2012 | 7604 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2024 | 1587 | 0.030 |
Why?
| | Biopsy, Needle | 1 | 2016 | 189 | 0.030 |
Why?
| | Drainage | 1 | 2016 | 173 | 0.030 |
Why?
| | United States | 5 | 2014 | 14841 | 0.030 |
Why?
| | Hemodynamics | 1 | 2019 | 1113 | 0.030 |
Why?
| | Age Distribution | 2 | 2005 | 392 | 0.030 |
Why?
| | Pain Measurement | 1 | 2016 | 521 | 0.030 |
Why?
| | Freezing | 1 | 2014 | 90 | 0.030 |
Why?
| | Thiazides | 1 | 2013 | 2 | 0.030 |
Why?
| | Lasers | 1 | 2014 | 130 | 0.030 |
Why?
| | Citrates | 1 | 2013 | 44 | 0.030 |
Why?
| | Allopurinol | 1 | 2013 | 63 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2003 | 1809 | 0.030 |
Why?
| | Clinical Competence | 2 | 2011 | 1118 | 0.020 |
Why?
| | Xanthine Oxidase | 1 | 2013 | 81 | 0.020 |
Why?
| | Kallikreins | 1 | 2012 | 29 | 0.020 |
Why?
| | Mutation | 1 | 2023 | 3958 | 0.020 |
Why?
| | Models, Anatomic | 1 | 2012 | 93 | 0.020 |
Why?
| | Matched-Pair Analysis | 1 | 2011 | 39 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1946 | 0.020 |
Why?
| | Germany | 1 | 2011 | 121 | 0.020 |
Why?
| | Asia | 1 | 2011 | 71 | 0.020 |
Why?
| | South America | 1 | 2011 | 60 | 0.020 |
Why?
| | Adolescent | 2 | 2008 | 21513 | 0.020 |
Why?
| | Equipment Reuse | 1 | 2011 | 16 | 0.020 |
Why?
| | Posture | 1 | 2011 | 185 | 0.020 |
Why?
| | Equipment and Supplies | 1 | 2009 | 42 | 0.020 |
Why?
| | Swine | 1 | 2012 | 775 | 0.020 |
Why?
| | Occupational Diseases | 1 | 2011 | 156 | 0.020 |
Why?
| | Organizational Objectives | 1 | 2009 | 73 | 0.020 |
Why?
| | Risk | 1 | 2012 | 912 | 0.020 |
Why?
| | Registries | 2 | 2009 | 2035 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2014 | 1738 | 0.020 |
Why?
| | Ovarian Cysts | 1 | 2008 | 6 | 0.020 |
Why?
| | Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2008 | 8 | 0.020 |
Why?
| | Congresses as Topic | 1 | 2009 | 233 | 0.020 |
Why?
| | Cystectomy | 1 | 2008 | 37 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2011 | 591 | 0.020 |
Why?
| | Osmolar Concentration | 1 | 2008 | 171 | 0.020 |
Why?
| | Culture Media | 1 | 2008 | 165 | 0.020 |
Why?
| | Cyclooxygenase 2 | 1 | 2008 | 178 | 0.020 |
Why?
| | Patient Selection | 1 | 2011 | 696 | 0.020 |
Why?
| | Interprofessional Relations | 1 | 2009 | 283 | 0.020 |
Why?
| | Cell Hypoxia | 1 | 2008 | 226 | 0.020 |
Why?
| | Blotting, Western | 1 | 2009 | 1226 | 0.020 |
Why?
| | Cell Cycle | 1 | 2009 | 601 | 0.020 |
Why?
| | Surveys and Questionnaires | 2 | 2011 | 5778 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2009 | 1389 | 0.010 |
Why?
| | Cell Survival | 1 | 2008 | 1120 | 0.010 |
Why?
| | Health Surveys | 1 | 2006 | 514 | 0.010 |
Why?
| | Cell Movement | 1 | 2009 | 967 | 0.010 |
Why?
| | Brachytherapy | 1 | 2005 | 121 | 0.010 |
Why?
| | SEER Program | 1 | 2005 | 227 | 0.010 |
Why?
| | Sex Distribution | 1 | 2005 | 375 | 0.010 |
Why?
| | Health Services Research | 1 | 2006 | 404 | 0.010 |
Why?
| | Chi-Square Distribution | 1 | 2005 | 530 | 0.010 |
Why?
| | Biomedical Research | 1 | 2009 | 692 | 0.010 |
Why?
| | Gene Expression | 1 | 2008 | 1502 | 0.010 |
Why?
| | Colorado | 1 | 2012 | 4565 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 2006 | 1483 | 0.010 |
Why?
| | Epithelial Cells | 1 | 2008 | 1096 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2009 | 3412 | 0.010 |
Why?
| | Socioeconomic Factors | 1 | 2005 | 1289 | 0.010 |
Why?
| | Physician-Patient Relations | 1 | 2004 | 548 | 0.010 |
Why?
| | Recurrence | 1 | 2003 | 1060 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2003 | 2486 | 0.010 |
Why?
| | Rats | 1 | 2003 | 5647 | 0.010 |
Why?
| | Young Adult | 1 | 2010 | 13209 | 0.010 |
Why?
|
|
Kim's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|